Hyderabad’s Centre for Cellular and Molecular Biology (CCMB) is part of a group of researchers developing a genetic algorithm similar to ChatGPT. This algorithm uses genome sequencing data to predict disease-causing genetic mutations in patients, instead of human language. The research group, which includes the Institute of Evolutionary Biology, Pompeu Fabra University, Illumina, Baylor College of Medicine, CCMB, and others, has collected an extensive catalog of genomic information for primates. Illumina, a leading DNA sequencing company, used this information to develop an AI algorithm with clinical applications for identifying insights into the genetic causes of human disease. The PrimateAI-3D deep learning algorithm, developed by Illumina, identifies disease-causing genetic mutations with unprecedented accuracy.
The Centre for Cellular and Molecular Biology (CCMB) is a premier research organization in India that focuses on cellular and molecular biology. It was established in 1977 as a research division of the Council of Scientific and Industrial Research (CSIR). The CCMB’s primary objective is to conduct innovative research in molecular and cellular biology, with an emphasis on addressing challenges related to human health and disease.
Illumina is a leading company in the field of DNA sequencing and genetic research. It offers next-generation sequencing technology and related products for genomic research purposes. The company’s goal is to advance the understanding of the human genome and enable researchers to improve human health outcomes. Illumina has been involved in several groundbreaking genetic research collaborations and has developed advanced AI algorithms, including the PrimateAI-3D, which can identify disease-causing genetic mutations in patients with unprecedented accuracy.
